semaglutide and general anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia Are Serious Anesthesia Risks of

Trata-se de uma molcula que age nos receptores de trs hormnios envolvidos com o mecanismo de fome e saciedade, e tambm com os nveis de glicose e insulina no sangue, o GLP-1, GIP e glucagon

This injectable medication mimics the effects of a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which regulates blood sugar levels and, notably, plays a role in appetite control

They differ in oversight pathway, presentation, and cost

Semaglutide has been rigorously tested and approved by the FDA for chronic weight management

Challenges such as solubility limitations and non-specific binding must be carefully managed

Merlo A, DElia E, Di Odoardo L, Sciatti E, Senni M